Having a migraine is hard. It can be even harder to watch your child experience a painful and debilitating migraine without the ability to help.
We are inviting you to take part in a clinical study for children and adolescents of 6 to 17 years of age who suffer from migraines. All study-related visits, tests, and investigational product will be provided at no cost. In addition, you may receive compensation for your time and travel. No health insurance is required to participate.
The PERISCOPE Study is evaluating an investigational product for the treatment of migraines in children and adolescents between the ages of 6 to 17. The investigational product is currently approved to treat migraines in adults.
You or your child may qualify for the PERISCOPE Study if you or they:
- Are between the ages of 6-17 years old
- Have been experiencing migraines for at least 6 months
- Experience between 1 and 14 migraine attacks per month
Sign Up
What happens if I sign up? We will match you or your child to a study site location in your area that needs participants between the ages of 6-17 who experience migraines or notify you when one becomes available. The study team will then contact you and you may have the opportunity to participate if you or your child qualify.
If you think you or your child might like to participate in the PERISCOPE Study or would like more information, please enter your or your child’s information below so we can see if you or your child may qualify and can contact you about the studies. Keep in mind that participation is entirely voluntary. If you do decide to take part in a study, you may change your mind about participating at any time.
If you are under the age of 13 (or 16 if you are in California or in Europe), you may not directly enter any information and your legal parent or guardian must enter this information on your behalf. By filling out this form, you are confirming that you meet these requirements.
About Pediatric Migraine Disease
Migraine is a severe, chronic neurological disease characterized by episodic attacks of moderate-to-severe headache, sensory disturbances, and other symptoms. Migraine disease represents a major cause of disability in adults and in children.
Although the peak prevalence of the condition typically occurs during adulthood, migraine disease represents one of the most common childhood ailments.1
The prevalence of migraine disease in children and adolescents is estimated at 7% to 10%, and about one-third of people with migraine disease experience their first attack before adulthood.2 Among children, a headache is the most common symptom and the most common source of pain when experiencing a migraine attack.3
An accurate and timely diagnosis of migraine disease is vital to ensure prompt treatment of the disease. Earlier diagnosis and treatment may lead to a more favorable outcome and to lowered risk of medication overuse and of progression from episodic to chronic migraine.4 To diagnose migraines in children, the same criteria are used to diagnose adults, but with differences in duration.5
The PERISCOPE Study is evaluating an investigational product for the treatment of migraines in children and adolescents between the ages of 6 to 17. The investigational product is currently approved to treat migraines in adults.
Frequently Asked Questions
What is a clinical study?
A clinical study (also called a clinical trial) is a medical study that helps to answer important questions about an investigational drug – these may include how well an investigational study drug works for a certain condition. All medications must be tested in clinical research studies before they can be approved and prescribed to patients.
Why are clinical studies important?
A clinical study is the basis on which investigational products are evaluated to determine if they can be approved and brought to market. Even over-the-counter medications, such as NSAIDs, that you may have used to counteract a headache, have gone through the clinical research study process before it was available at your local pharmacy.
What is the purpose of the PERISCOPE Study?
The PERISCOPE Study is evaluating an investigational product for the treatment of migraines in children and adolescents between the ages of 6 to 17.
The investigational product is currently approved to treat migraines in adults.
What will the PERISCOPE Study involve?
The PERISCOPE Study will last as short as several weeks or for up to 6 months. Over 1000 participants will be enrolled in the study, which is being conducted at approximately 120 study sites across the United States.
Eligible participants will receive the investigational product or the placebo. The study team will provide more information when they contact you.
Will I be compensated?
Participants who qualify to take part in the study may receive compensation for time and travel. Please discuss this with the study team when they contact you.
Is there a cost to participate?
There is no cost to participate in the PERISCOPE Study. If you decide to take part:
- You will receive study-related care throughout the study from a team of experienced doctors and nurses
- All study-related visits, tests, and investigational product will be provided at no cost.
What else do I need to consider?
The research team will be able to explain more about what the PERISCOPE Study will involve, and it is up to you to decide if you want to take part. Participation in this study is voluntary. Whether or not you decide to participate in this study will not affect your current or future relationships with your doctors. If you decide to participate, you are free to withdraw at any time without affecting those relationships.
How far is the study site?
We match you to a study site within a close travel distance from your home. If we are not running the study in your area currently, with your permission, we will keep you in our database and reach out once a study in your area becomes available. If, at any time, you decided you no longer want your information stored, you can opt out and we will delete your details.
About the PERISCOPE Study
The PERISCOPE Study will enroll over 1000 participants between the ages of 6 to 17 years old who suffer from migraines at approximately 120 study sites in the United States.
The study will include 2-3 visits to a study site in your location. Your or your child’s participation may be as short as several weeks or for up to 6 months. After completing this study, you or your child may have the opportunity to participate in the extension study for approximately 1 year.
Participants will receive all study-related visits, tests, and care from a dedicated medical team at no cost.
Who can take part in the PERISCOPE Study?
You, or your child may qualify for the PERISCOPE Study if you or they:
- Are between the ages of 6-17 years old
- Have been experiencing migraines for at least 6 months
- Experience between 1 and 14 migraine attacks per month
All study-related visits, tests, and investigational product will be provided at no cost to you or your insurance. In addition, compensation for time and travel may be provided.
The PERISCOPE Study is evaluating an investigational product for the treatment of migraines in children and adolescents between the ages of 6 to 17. The investigational product is currently approved to treat migraines in adults.